South Korea's EuBiologics Co. announced on Friday that the vaccine bulk production facility at its Chuncheon Plant No. 2 for the oral cholera vaccin...

OCI Holdings Co., South Korea’s largest polysilicon maker, is looking abroad to acquire a biopharmaceutical company in the US in a consortium, ...

MedInTech Inc., South Korea's medical smart endoscopes startup, announced on Monday that it attracted a series B investment of 20 billion won ($14.6 ...

South Korea’s Samsung Medison, a medical equipment subsidiary of the global memory chipmaker Samsung Electronics Co., is taking over France&rsq...

The global weight management market has entered a new chapter following the arrival of blockbuster weight-loss medication Wegovy, and South Korean la...

Samsung Life Science Fund, managed by Samsung Group’s venture investment arm, has invested in US biotechnology firm Latus Bio Inc. during the l...

South Korean medical AI company Lunit announced on Thursday that it partnered with the Danish musculoskeletal AI diagnostics company Radiobotics ApS ...

South Korea's Celltrion Inc. announced on Thursday that it secured a contract to supply its biosimilars for autoimmune disease treatment and anticanc...

South Korea’s JLK Inc., an AI-based stroke care platform maker, announced on Tuesday that it signed a business agreement with medical consultin...

South Korean medical diagnostic company NGeneBio Co. announced on Tuesday that it signed a contract with the United Arab Emirates (UAE)-based medical...

South Korea is ramping up exports of botulinum toxin to the US and China, the world’s two top consumers of the neurotoxin protein, with its pri...

South Korean bio-health company HK inno.N announced on Tuesday that it signed a contract with Saudi Arabian local pharmaceutical company Tabuk Pharma...

South Korea's Samsung Bioepis has received approval from the European Commission to sell Pyzchiva, a biosimilar of the autoimmune disease Stelara. Th...

South Korea's Celltrion Inc. announced on Thursday that it released its autoimmune disease treatment Remsima SC (infliximab) in Denmark. Remsima SC i...

Celltrion Inc. and SK Biopharmaceuticals Co. are witnessing improving sales revenue and profitability by selling their products through their own mar...

South Korean bio startup ArtBlood, specializing in blood production for transfusion, announced on Tuesday that it successfully secured an investment ...

The two sons of Hanmi Pharmaceutical Group’s founding family, who were approved as board members of the holding firm Hanmi Science Co. at its s...

Genesystem, a South Korean biotech company said on Tuesday that it will export 20 on-site tuberculosis (TB) diagnostic devices and 6,000 TB test kits...

NEW YORK/ BOSTON – Longevity has long been the dream of humankind. China’s first emperor Qin Shi Huang was obsessed with finding magic el...

South Korea's biopharmaceutical firm Medytox Inc. announced on Tuesday that it signed a contract with Brazilian pharmaceutical company Blau Farmaceut...

Samsung Bioepis Co., a biosimilar development unit of South Korea’s top conglomerate Samsung Group, has begun its new drug development business...

South Korea's SK Bioscience Co. announced on Thursday that it has shipped about 440,000 doses (for single-dose administration) of its cell-cultured i...

Boryung Corp., formerly Boryung Pharmaceutical Co., aims to join the 1 trillion won ($748 million) sales club this year, driven by new chronic diseas...

Samsung Group announced on Tuesday that its Life Science Fund has invested in the US-based antibody-drug conjugates (ADC) and gene therapy technolog...

Humans will be able to control biological age and reverse their age in 10 years with advancements in medical science and live up to around 120, about...

South Korean biopharmaceutical giant Celltrion Inc. said on March 17 that it has launched its new autoimmune disease treatment Zymfentra in the US ma...

Vivid Health, a South Korean startup that operates an obesity treatment management platform announced on Wednesday that it got a seed round investmen...

South Korea's Celltrion Inc. announced on Wednesday that it shipped the first supply of its subcutaneous injection type of the autoimmune disease tre...

CHEONGJU, North Chungcheong Province -- South Korea’s major pharmaceutical company GC Biopharma Corp. aims to raise the sales of Alyglo, its im...